Instinct Bio Technical Company Holdings Inc. (BIOT)
NASDAQ: BIOT · Real-Time Price · USD
0.3998
-0.0084 (-2.06%)
At close: Sep 3, 2026, 4:00 PM EDT
0.3955
-0.0043 (-1.08%)
Pre-market: Sep 4, 2026, 5:52 AM EDT
Company Description
Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution.
It has a strategic collaboration with PT Parva Candela to develop cosmetics business in Indonesia. The company was founded in 2011 and is headquartered in Tokyo, Japan.
Instinct Bio Technical Company Holdings Inc.
| Country | Japan |
| Founded | 2017 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| CEO | Tomoki Nagano |
Contact Details
| Website | instinct-biot.com |
Stock Details
| Ticker Symbol | BIOT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 2072186 |
| CUSIP Number | G4860C107 |
| ISIN Number | KYG4860C1078 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Dr. Michael Shleifer Ph.D. | Chairman and Chief Executive Officer |
| Thomas Fratacci | Chief Financial Officer and Treasurer |
| Ivan Jarry | Chief Operating Officer |
| Albert F. Hummel M.B.A. | Chief Investment Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 26, 2026 | 425 | Filing |
| Dec 3, 2025 | EFFECT | Notice of Effectiveness |
| Nov 25, 2025 | POS AM | Post-Effective amendments for registration statement |
| Oct 24, 2025 | F-4/A | Filing |
| Sep 26, 2025 | F-4/A | Filing |
| Sep 17, 2025 | UPLOAD | Filing |
| Sep 17, 2025 | 425 | Filing |
| Sep 9, 2025 | F-4 | Filing |
| Aug 26, 2025 | UPLOAD | Filing |
| Aug 12, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |